Magnetotherapy

Introduced: January 1990

Last revised: January 2006

Classification Context

Section:: HUMAN NECESSITIES
Class:: MEDICAL OR VETERINARY SCIENCE; HYGIENE
Subclass:: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY

Filing statistics

IPC A61N 2/00 belongs to the parent subclass A61N, which recorded 197,020 patent applications worldwide between 2013 and 2023. Annual filings grew from 12,218 in 2013 to 18,252 in 2023 (+49%), peaking at 23,085 applications in 2020. The most active applicants in class A61 are PHILIPS ELECTRONICS (18,523 applications), NOVARTIS (14,253 applications) and COVIDIEN (13,953 applications).

Source: EPO PATSTAT, worldwide filings

Related Keywords

MAGNETO THERAPY, MAGNETO-THERAPYmagneto- THERAPY

3 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets
A61N 2/06 using magnetic fields produced by permanent magnets
A61N 2/12 using variable magnetic fields obtained by mechanical movement

Top Applicants

Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT

PHILIPS ELECTRONICS NL 18,523
NOVARTIS CH 14,253
COVIDIEN US 13,953
ROCHE CH 12,005
CHINESE ACADEMY OF SCIENCES 11,955
UNIVERSITY OF CALIFORNIA US 11,692
HARVARD UNIVERSITY US 11,596
L'OREAL FR 11,593
P&G (PROCTER & GAMBLE COMPANY) US 11,297
OLYMPUS CORPORATION JP 9,594